What is the ticker symbol for Talaris Therapeutics?

Talaris Therapeutics trades under the ticker TALS on NASDAQ.

What sector does Talaris Therapeutics operate in?

Talaris Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TALS in a portfolio?

PortView shows TALS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Talaris Therapeutics (TALS) Stock Analysis

NASDAQHealthcareBiotechnology

$2.72-0.73%

1-year price historyRange $0.94 – $3.22

52-week range$2.72

$0.89$3.29

Track TALS in your portfolio for free · Portfolio tracker

What Talaris Therapeutics does

Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.

Key metrics

Market cap

$116.44M

P/E (TTM)

-1.56

EPS (TTM)

$-1.74

Beta

2.18

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.83

200-day avg

$2.44

52-week high

$3.29

52-week low

$0.89

CEO

Mary Kay Fenton

ETFs linked to TALS

Broad-market and Healthcare sector ETFs an investor holding Talaris Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TALS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TALS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Talaris Therapeutics?: Talaris Therapeutics trades under the ticker TALS on NASDAQ.
Which exchange is TALS listed on?: TALS is listed on NASDAQ.
What sector does Talaris Therapeutics operate in?: Talaris Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TALS in a portfolio?: PortView shows TALS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.